{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:07:58Z","timestamp":1791205678621,"version":"4.1.0"},"publisher-location":"Berlin, Heidelberg","reference-count":51,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783642247156","type":"print"},{"value":"9783642247163","type":"electronic"}],"license":[{"start":{"date-parts":[[2011,12,10]],"date-time":"2011-12-10T00:00:00Z","timestamp":1323475200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2011,12,10]],"date-time":"2011-12-10T00:00:00Z","timestamp":1323475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012]]},"DOI":"10.1007\/978-3-642-24716-3_16","type":"book-chapter","created":{"date-parts":[[2012,1,16]],"date-time":"2012-01-16T12:20:09Z","timestamp":1326716409000},"page":"349-356","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["5-HT2C Receptor Agonists and the Control of Appetite"],"prefix":"10.1007","author":[{"given":"Jason C. G.","family":"Halford","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne A.","family":"Harrold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,12,10]]},"reference":[{"key":"16_CR1_16","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1056\/NEJM199608293350901","volume":"335","author":"L Abeniam","year":"1996","unstructured":"Abeniam L, Moride Y, Brenot F et al (1996) Appetite suppressant drugs and the risk of primary pulmonary hypertension. N Engl J Med 335:609\u2013616","journal-title":"N Engl J Med"},{"key":"16_CR3_16","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1001\/archinte.164.9.994","volume":"164","author":"DE Arterburn","year":"2004","unstructured":"Arterburn DE, Crane PK, Veenstra DL (2004) The efficacy and safety of sibutramine for weight loss: a systematic review. Arch Intern Med 164:994\u20131003","journal-title":"Arch Intern Med"},{"issue":"Suppl. 1","key":"16_CR5_16","first-page":"214","volume":"28","author":"C Bjenning","year":"2004","unstructured":"Bjenning C, Williams J, Whelan K et al (2004) Chronic oral administration of APD356 significantly reduces body weight and fat mass in obesity-prone (DIO) male and female rats. Int J Obes 28(suppl 1):214","journal-title":"Int J Obes"},{"key":"16_CR6_16","first-page":"15","volume":"1","author":"JE Blundell","year":"1977","unstructured":"Blundell JE (1977) Is there a role for serotonin (5-hydroxytryptamine) in feeding? Int J Obes 1:15\u201342","journal-title":"Int J Obes"},{"key":"16_CR7_16","doi-asserted-by":"publisher","first-page":"473","DOI":"10.2165\/00023210-199809060-00005","volume":"9","author":"JE Blundell","year":"1998","unstructured":"Blundell JE, Halford JCG (1998) Serotonin and appetite regulation: implications for the treatment of obesity. CNS Drugs 9:473\u2013495","journal-title":"CNS Drugs"},{"key":"16_CR8_16","first-page":"219","volume":"14","author":"JE Blundell","year":"1990","unstructured":"Blundell JE, Hill AJ (1990) Sensitivity of the appetite control system in obese subjects to nutritional and serotoninergic challenges. Int J Obes 14:219\u2013233","journal-title":"Int J Obes"},{"key":"16_CR9_16","first-page":"83","volume-title":"Central mechanisms of anorectic drugs","author":"JE Blundell","year":"1978","unstructured":"Blundell JE, Latham CJ (1978) Pharmacological manipulation of feeding behaviour: possible influences of serotonin and dopamine on food intake. In: Garattini S, Samanin R (eds) Central mechanisms of anorectic drugs. Raven, NY, pp 83\u2013109"},{"key":"16_CR10_16","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/0091-3057(80)90155-0","volume":"12","author":"JE Blundell","year":"1980","unstructured":"Blundell JE, Latham CJ (1980) Characteristic adjustments to the structure of feeding behaviour following pharmacological treatments: effects of amphetamine and fenfluramine and the antagonism by pimozide and metergoline. Pharmacol Biochem Behav 12:717\u2013722","journal-title":"Pharmacol Biochem Behav"},{"key":"16_CR11_16","first-page":"19","volume-title":"Anorectic agents: mechanisms of action and tolerance","author":"JE Blundell","year":"1981","unstructured":"Blundell JE, McArthur RA (1981) Behavioural flux and feeding: continuous monitoring of food intake and food selection, and the video-recording of appetitive and satiety sequences for the analysis of drug action. In: Samanin R, Garattini S (eds) Anorectic agents: mechanisms of action and tolerance. Raven, NY, pp 19\u201343"},{"key":"16_CR12_16","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0031-9384(99)00176-6","volume":"68","author":"D Chapelot","year":"2000","unstructured":"Chapelot D, Mamonier C, Thomas F et al (2000) Modalities of the food intake-reducing effect of sibutramine in humans. Physiol Behav 68:299\u2013308","journal-title":"Physiol Behav"},{"key":"16_CR13_16","first-page":"313","volume-title":"Ethology and psychopharmacology","author":"PG Clifton","year":"1994","unstructured":"Clifton PG (1994) The neuropharmacology of meal patterning. In: Cooper SJ (ed) Ethology and psychopharmacology. Wiley, Chichester, pp 313\u2013328"},{"key":"16_CR14_16","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/hup.470100504","volume":"10","author":"PJ Cowen","year":"1995","unstructured":"Cowen PJ, Sargent PA, Williams C et al (1995) Hypophagic, endocrine and subjective responses to m-chlorophenylpiperazine in healthy men and women. Hum Psychopharmacol 10:385\u2013391","journal-title":"Hum Psychopharmacol"},{"key":"16_CR15_16","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S0195-6663(88)80004-7","volume":"11","author":"E Goodall","year":"1988","unstructured":"Goodall E, Silverstone T (1988) Differential effect of d-fenfluramine and metergoline on food intake in human subjects. Appetite 11:215\u2013288","journal-title":"Appetite"},{"key":"16_CR16_16","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/sj.ijo.0801889","volume":"26","author":"CK Haddock","year":"2002","unstructured":"Haddock CK, Poston WSC, Dill PL et al (2002) Pharmacotherapy for obesity: a quantitative analysis of four decades of published randomized clinical trials. Int J Obes 26:262\u2013273","journal-title":"Int J Obes"},{"key":"16_CR17_16","first-page":"95","volume":"100","author":"JCG Halford","year":"1993","unstructured":"Halford JCG, Blundell JE (1993) 5-Hydroxytryptaminergic drugs compared on the behavioural sequence associated with satiety. Br J Pharmacol 100:95","journal-title":"Br J Pharmacol"},{"key":"16_CR18_16","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1177\/0269881108095195","volume":"24","author":"JCG Halford","year":"2010","unstructured":"Halford JCG, Boyland EJ, Cooper SJ et al (2010a) The effects of sibutramine on the microstructure of eating behaviour and energy expenditure in obese women. J Psychopharmacol 24:99\u2013109","journal-title":"J Psychopharmacol"},{"key":"16_CR19_16","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nrendo.2010.19","volume":"6","author":"JCG Halford","year":"2010","unstructured":"Halford JCG, Boyland EJ, Blundell JE et al (2010b) Pharmacological management of human appetite expression: evaluating the effects of novel anti-obesity agents on eating behaviour. Nat Endocrine Rev 6:255\u2013269","journal-title":"Nat Endocrine Rev"},{"key":"16_CR20_16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2165\/00003495-200767010-00004","volume":"67","author":"JCG Halford","year":"2007","unstructured":"Halford JCG, Harrold JA, Boyland EJ, Lawton CL, Blundell JE (2007) Serotonergic drugs: effects on appetite expression and use for the treatment of obesity. Drugs 67:27\u201355","journal-title":"Drugs"},{"key":"16_CR21_16","doi-asserted-by":"publisher","first-page":"222","DOI":"10.3109\/07853890008998829","volume":"32","author":"JCG Halford","year":"2000","unstructured":"Halford JCG, Blundell JE (2000) Separate systems for serotonin and leptin in appetite control. Ann Med 32:222\u2013232","journal-title":"Ann Med"},{"key":"16_CR22_16","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0091-3057(98)00032-X","volume":"61","author":"JCG Halford","year":"1998","unstructured":"Halford JCG, Wanninayake SCD, Blundell JE (1998) Behavioural satiety sequence (BSS) for the diagnosis of drug action on food intake. Pharmacol Biochem Behav 61:159\u2013168","journal-title":"Pharmacol Biochem Behav"},{"key":"16_CR23_16","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1093\/ajcn\/68.6.1180","volume":"68","author":"DL Hansen","year":"1998","unstructured":"Hansen DL, Toubro S, Stock MJ et al (1998) Thermogenic effects of sibutramine in humans. Am J Clin Nutr 68:1180\u20131186","journal-title":"Am J Clin Nutr"},{"key":"16_CR24_16","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.brainres.2004.03.032","volume":"1011","author":"A Hayashi","year":"2004","unstructured":"Hayashi A, Sonoda R, Kimura Y et al (2004) Antiobesity effect of YM348, a novel 5-HT2C receptor agonist, in Zucker rats. Brain Res 1011:221\u2013227","journal-title":"Brain Res"},{"key":"16_CR25_16","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1126\/science.1072327","volume":"297","author":"LK Heisler","year":"2002","unstructured":"Heisler LK, Cowley MA, Tecott LH et al (2002) Activation of Central Melanocortin pathways by Fenfluramine. Science 297:609\u2013611","journal-title":"Science"},{"key":"16_CR26_16","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1749-6632.2003.tb03177.x","volume":"994","author":"LK Heisler","year":"2003","unstructured":"Heisler LK, Cowley MA, Kishi T et al (2003) Central serotonin and melanocortin pathways regulating energy homeostasis. N Y Acad Sci 994:169\u2013174","journal-title":"N Y Acad Sci"},{"key":"16_CR27_16","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.neuron.2006.06.004","volume":"51","author":"LK Heisler","year":"2006","unstructured":"Heisler LK, Jobst EE, Sutton GM et al (2006) Serotonin reciprocally regulates melanocortin neurons to modulate food intake. Neuron 51:239\u2013249","journal-title":"Neuron"},{"key":"16_CR28_16","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/S0091-3057(01)00709-2","volume":"71","author":"KN Hewitt","year":"2002","unstructured":"Hewitt KN, Lee MD, Dourish CT et al (2002) Serotonin 2C receptor agonists and the behavioural satiety sequence in mice. Pharmacol Biochem Behav 71:691\u2013700","journal-title":"Pharmacol Biochem Behav"},{"key":"16_CR29_16","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1007\/s00213-010-2106-2","volume":"214","author":"S Higgs","year":"2011","unstructured":"Higgs S, Cooper AJ, Barnes NM (2011) Reversal of sibutramine-induced anorexia with a selective 5-HT2C receptor antagonist. Psychopharmacology 214:941\u2013947","journal-title":"Psychopharmacology"},{"key":"16_CR30_16","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0028-3908(97)00036-1","volume":"36","author":"D Hoyer","year":"1997","unstructured":"Hoyer D, Martin G (1997) 5-HT receptor classification and nomenclature: towards a harmonization with the human genome. Neuropharmacology 36:419\u2013428","journal-title":"Neuropharmacology"},{"key":"16_CR31_16","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1056\/NEJMoa1003114","volume":"363","author":"WP James","year":"2010","unstructured":"James WP, Caterson ID, Coutinho W, Finer N, Van Gaal LF, Maggioni AP, Torp-Pedersen C, Sharma AM, Shepherd GM, Rode RA, Renz CL, SCOUT Investigators (2010) Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects. N Engl J Med 363:905\u2013917","journal-title":"N Engl J Med"},{"key":"16_CR32_16","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/BF02431539","volume":"96","author":"GA Kennett","year":"1988","unstructured":"Kennett GA, Curzon G (1988a) Evidence that the hypophagia induced by mCPP and TFMPP requires 5-HT1C and 5-HT1B receptors; hypophagia induced by RU-24969 only requires 5-HT1B receptors. Psychopharmacology 96:93\u2013100","journal-title":"Psychopharmacology"},{"key":"16_CR33_16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1476-5381.1988.tb11508.x","volume":"94","author":"GA Kennett","year":"1988","unstructured":"Kennett GA, Curzon G (1988b) Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors. Br J Pharmacol 94:137\u2013147","journal-title":"Br J Pharmacol"},{"key":"16_CR34_16","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1007\/BF02245211","volume":"113","author":"SJ Kitchener","year":"1994","unstructured":"Kitchener SJ, Dourish CT (1994) An examination of the behavioural specificity of hypophagia induced by 5-HT1B, 5-HT1C and 5-HT2 receptor agonists using the post-prandial sequence in rats. Psychopharmacology 113:368\u2013377","journal-title":"Psychopharmacology"},{"key":"16_CR35_16","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/j.1550-8528.1995.tb00160.x","volume":"3","author":"CL Lawton","year":"1995","unstructured":"Lawton CL, Wales JK, Hill AJ et al (1995) Serotoninergic manipulation, meal-induced satiety and eating patterns. Obes Res 3:345\u2013356","journal-title":"Obes Res"},{"key":"16_CR36_16","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1210\/jc.2010-1848","volume":"96","author":"CK Martin","year":"2011","unstructured":"Martin CK, Redman LM, Zhang J et al (2011) Lorcaserin, a 5-HT2C receptor agonist, reduced body weight by decreasing energy intake within influencing energy expenditure. J Clin Endocrinol Metab 96:837\u201345","journal-title":"J Clin Endocrinol Metab"},{"key":"16_CR37_16","first-page":"361","volume":"14","author":"J McGuirk","year":"1990","unstructured":"McGuirk J, Silverstone T (1990) The effect of 5-HT re-uptake inhibitor fluoxetine on food intake and body weight in healthy male subjects. Int J Obes 14:361\u2013372","journal-title":"Int J Obes"},{"key":"16_CR38_16","doi-asserted-by":"publisher","first-page":"315","DOI":"10.2337\/diabetes.52.2.315","volume":"52","author":"K Nonogaki","year":"2003","unstructured":"Nonogaki K, Abdullah L, Goulding EH et al (2003) Hyperactivity and reduced energy cost of physical activity in serotonin 5-HT2C receptor mutant mice. Diabetes 52:315\u2013320","journal-title":"Diabetes"},{"key":"16_CR39_16","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1038\/sj.ijo.0802475","volume":"27","author":"R Padwal","year":"2003","unstructured":"Padwal R, Li SK, Lau DCW (2003) Long-term pharmacotherapy for overweight and obesity: a systematic review and meta-analysis of randomized controlled trials. Int J Obes 27:1437\u201346","journal-title":"Int J Obes"},{"key":"16_CR40_16","first-page":"237","volume":"15","author":"H Pijl","year":"1991","unstructured":"Pijl H, Koppeschaar HPF, Willekens FLA et al (1991) Effect of serotonin re-uptake inhibition by fluoxetine on body weight and spontaneous food choice in obesity. Int J Obes 15:237\u2013242","journal-title":"Int J Obes"},{"key":"16_CR41_16","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/BF00427624","volume":"66","author":"PJ Rogers","year":"1979","unstructured":"Rogers PJ, Blundell JE (1979) Effect of anorexic drugs on food intake and the micro-structure of eating in human subjects. Psychopharmacology 66:159\u2013165","journal-title":"Psychopharmacology"},{"key":"16_CR42_16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/j.1550-8528.1998.tb00308.x","volume":"6","author":"BJ Rolls","year":"1998","unstructured":"Rolls BJ, Shide DJ, Thorward ML et al (1998) Sibutramine reduces food intake in non-dieting women with obesity. Obes Res 6:1\u201311","journal-title":"Obes Res"},{"key":"16_CR43_16","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s002130050407","volume":"133","author":"PA Sargent","year":"1997","unstructured":"Sargent PA, Sharpley AL, Williams C et al (1997) 5-HT2C receptor activation decreases appetite and body weight in obese subjects. Psychopharmacology 133:309\u2013312","journal-title":"Psychopharmacology"},{"key":"16_CR44_16","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/oby.2008.537","volume":"17","author":"SR Smith","year":"2009","unstructured":"Smith SR, Prosser WA, Donahue DF et al (2009) Lorcaserin (APD356), a selective 5-HT2C agonist, reducing body weight in obese men and women. Obesity 17:494\u2013500","journal-title":"Obesity"},{"key":"16_CR45_16","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1056\/NEJMoa0909809","volume":"363","author":"SR Smith","year":"2010","unstructured":"Smith SR, Wiessman NJ, Anderson CM et al (2010) Multicenter, placebo-controlled trial for Lorcaserin for weight management. N Engl J Med 363:245\u201356","journal-title":"N Engl J Med"},{"key":"16_CR46_16","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/374542a0","volume":"374","author":"LH Tecott","year":"1995","unstructured":"Tecott LH, Sun LM, Akanna SF et al (1995) Eating disorder and epilepsy in mice lacking 5-HT2C serotonin receptors. Nature 374:542\u2013546","journal-title":"Nature"},{"key":"16_CR47_16","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/sj.bjp.0703443","volume":"130","author":"SP Vickers","year":"2000","unstructured":"Vickers SP, Benwell KR, Porter RH et al (2000) Comparative effects of continuous infusion of mCPP, Ro 60\u20130175 and d-fenfluramine on food intake, water intake, body weight and locomotor activity in rats. Br J Pharmacol 130:1305\u20131314","journal-title":"Br J Pharmacol"},{"key":"16_CR48_16","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s002130050952","volume":"143","author":"SP Vickers","year":"1999","unstructured":"Vickers SP, Clifton PG, Dourish CT et al (1999) Reduced satiating effect of d-fenfluramine in serotonin 5-HT2C receptor mutant mice. Psychopharmacology 143:309\u2013314","journal-title":"Psychopharmacology"},{"key":"16_CR49_16","first-page":"377","volume":"5","author":"SP Vickers","year":"2004","unstructured":"Vickers SP, Dourish CT (2004) Serotonin receptor ligands and the treatment of obesity. Curr Opin Investig Drugs 5:377\u2013388","journal-title":"Curr Opin Investig Drugs"},{"key":"16_CR50_16","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0028-3908(01)00063-6","volume":"41","author":"SP Vickers","year":"2001","unstructured":"Vickers SP, Dourish CT, Kennett GA (2001) Evidence that hypophagia induced by d-fenfluramine and d-norfenfluramine in the rat is mediated by 5-HT2C receptors. Neuropharmacology 41:200\u2013209","journal-title":"Neuropharmacology"},{"key":"16_CR51_16","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s00213-002-1378-6","volume":"167","author":"SP Vickers","year":"2003","unstructured":"Vickers SP, Easton N, Webster LJ et al (2003) Oral administration of the 5-HT2C receptor agonist, mCPP, reduces body weight gain in rats over 28\u00a0days as a result of maintained hypophagia. Psychopharmacology 167:274\u2013280","journal-title":"Psychopharmacology"},{"key":"16_CR52_16","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1007\/BF02244883","volume":"116","author":"AE Walsh","year":"1994","unstructured":"Walsh AE, Smith KA, Oldman AD (1994) M-Chlorophenylpiperazine decreases food intake in a test meal. Psychopharmacology 116:120\u2013122","journal-title":"Psychopharmacology"},{"key":"16_CR53_16","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0031-9384(99)00020-7","volume":"66","author":"AS Ward","year":"1999","unstructured":"Ward AS, Comer SD, Haney M et al (1999) Fluoxetine-maintained obese humans: effect on food intake and body weight. Physiol Behav 66:815\u2013821","journal-title":"Physiol Behav"}],"container-title":["Handbook of Experimental Pharmacology","Appetite Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-24716-3_16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T05:43:51Z","timestamp":1675748631000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-642-24716-3_16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,10]]},"ISBN":["9783642247156","9783642247163"],"references-count":51,"URL":"https:\/\/doi.org\/10.1007\/978-3-642-24716-3_16","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,10]]},"assertion":[{"value":"10 December 2011","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}